Cancer Therapies

Pharma company presented six studies at cancer therapy conference

Published in Gene Therapy Weekly, November 4th, 2004

PharmaMar presented data from six studies, four of which were from pharmacogenomics research projects at the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics, held in Geneva, Switzerland.

Pharmacogenomics is the science that examines the inherited variations in genes that dictate drug response and explores the way these variations can be used to predict how a patient will respond to a given drug.

PharmaMar launched its pharmacogenomics research program 2 years ago on the basis of data generated from its clinical trials of Yondelis, Aplidin and Kahalalide F. Whereas all three of these drugs have been shown in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2004-11-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry